Clinical Significance of ErbB Receptor Family in Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="181964.fig.003a" src="https://static.hindawi.com/articles/au/volume-2012/181964/figures/181964.fig.003a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>EGFR for bladder cancer progression</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="181964.fig.003b" src="https://static.hindawi.com/articles/au/volume-2012/181964/figures/181964.fig.003b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>ErbB2 for bladder cancer death</td></tr></table></td></tr></table>

<table>Funnel plots of publication bias for EGFR and ErbB2. (a) No obvious funnel plot asymmetry was found for EGFR because only four studies were analyzed. (b) A substantial funnel plot asymmetry for ErbB2 was found, which suggests the existence of publication bias.</table>

Advances in Urology

fig3

Figure 3

Figure 3: Clinical Significance of ErbB Receptor Family in Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis 